Breaking down the barriers to cancer immunotherapy
- PMID: 16369561
- DOI: 10.1038/ni1205-1207
Breaking down the barriers to cancer immunotherapy
Abstract
Emerging insights into the mechanisms of activation and negative regulation of innate and adaptive immune cells are providing new opportunities for the development of safe and effective cancer vaccines.
Similar articles
-
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity.Semin Oncol. 2015 Aug;42(4):562-72. doi: 10.1053/j.seminoncol.2015.05.012. Epub 2015 Jun 3. Semin Oncol. 2015. PMID: 26320061 Free PMC article. Review.
-
Roles for Innate Immunity in Combination Immunotherapies.Cancer Res. 2017 Oct 1;77(19):5215-5221. doi: 10.1158/0008-5472.CAN-17-1340. Epub 2017 Sep 19. Cancer Res. 2017. PMID: 28928130 Free PMC article. Review.
-
Cooperativity of adaptive and innate immunity: implications for cancer therapy.Cancer Immunol Immunother. 2011 Aug;60(8):1061-74. doi: 10.1007/s00262-011-1053-z. Epub 2011 Jun 9. Cancer Immunol Immunother. 2011. PMID: 21656157 Free PMC article. Review.
-
Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.Recent Pat Anticancer Drug Discov. 2018;13(1):2-17. doi: 10.2174/1574892812666171030163804. Recent Pat Anticancer Drug Discov. 2018. PMID: 29086701 Review.
-
Harnessing the immune system to treat cancer.J Clin Invest. 2007 May;117(5):1130-6. doi: 10.1172/JCI32136. J Clin Invest. 2007. PMID: 17476342 Free PMC article. Review.
Cited by
-
Indoleamine 2,3-dioxygenase and tumor-induced tolerance.J Clin Invest. 2007 May;117(5):1147-54. doi: 10.1172/JCI31178. J Clin Invest. 2007. PMID: 17476344 Free PMC article. Review.
-
Glucocorticoid-induced tumor necrosis factor receptor stimulation enhances the multifunctionality of adoptively transferred tumor antigen-specific CD8+ T cells with tumor regression.Cancer Sci. 2009 Jul;100(7):1317-25. doi: 10.1111/j.1349-7006.2009.01179.x. Epub 2009 Apr 29. Cancer Sci. 2009. PMID: 19432889 Free PMC article.
-
Meta-analysis of the cytotoxic T-lymphocyte antigen 4 gene +6230G/A polymorphism and cancer risk.Clin Transl Oncol. 2014 Oct;16(10):879-85. doi: 10.1007/s12094-014-1159-9. Epub 2014 Feb 4. Clin Transl Oncol. 2014. PMID: 24493286
-
Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis.Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E874-83. doi: 10.1073/pnas.1521359113. Epub 2016 Feb 1. Proc Natl Acad Sci U S A. 2016. PMID: 26831100 Free PMC article.
-
Cytotoxic T lymphocyte-associated antigen-4 +49A>G polymorphism and the risk of non-small cell lung cancer in a Chinese population.Int J Clin Exp Med. 2015 Jul 15;8(7):11519-23. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26379973 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources